T79630
CDK9-IN-25
TargetMol
DESCRIPTION
CDK9-IN-25 (compound 4a), an imidazopyrazine derivative, functions as a CDK9 inhibitor with an IC50 of 0.24 μM. It also exhibits affinity for the main protease of COVID-19 and demonstrates antiviral activity against human coronavirus 229E, with an IC50 of 63.28 μM [1].
DETAILS
- Purity: 98%
- Category: Compound
- Molecular Weight: 285.32
- Molecular Formula: C15H16FN5
Lead Time: 4 - 5 weeks
Sign in to view pricing